Nova Mentis Launches Autism Clinical Study
Ryan Allway May 6th, 2021 Psychedelics VANCOUVER, BC, May 6, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders, is pleased to announce that its North American autism... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )